Targeted Drug Delivery : Concepts and Design

1 Targeted Drug Delivery Systems - Strategies and Challenges.- 2 Recent Advances in Tumor Targeting Approaches.- 3 Infectious Diseases: Need for Targeted Drug Delivery.- 4 Image-Guided Delivery of Therapeutics to the Brain.- 5 Inhalation Therapy for Pulmonary Tuberculosis .- 6 Hepatic Targeting: Physiological Basis and Design Strategy.- 7 Targeted Drug Delivery to the Mitochondria.- 8 Targeted Delivery of Nucleic Acid Therapeutics via Non-viral Vectors.- 9 Mucosal Vaccine Delivery and M Cell Targeting.- 10 Stimuli responsive carriers: Magnetically, Thermal and pH Assisted Drug Delivery.- 11 Prodrug Conjugate Strategies for Targeted Anticancer Drug Delivery Systems.- 12 Polymer-Drug Conjugates for Targeted Drug Delivery.- 13 Functionalized Lipid Particulates in Targeted Drug Delivery.- 14 Nanoemulsions in Drug Targeting.- 15 Multifunctional Polymeric Nano-Carriers in Targeted Drug Delivery.- 16 Polymeric Micelles in Targeted Drug Delivery.- 17 Dendritic Polymers in Targeted Drug Delivery.- 18 Inorganic Nanoparticles in Targeted Drug Delivery and Imaging.- 19 Carbon-based Nanomaterials for Targeted Drug Delivery and Imaging.- 20 Physical and Biophysical Characteristics of Nanoparticles: Potential Impact on Targeted Drug Delivery.- 21 In Vivo Imaging Techniques of the Nanocarriers used for Targeted Drug Delivery.- 22 Evaluation of Lung Toxicity of Biodegradable Nanoparticles.- 23 Nanotoxicology: Contemporary Issues and Future Directions.

Prof. Padma V. Devarajan is Professor in Pharmacy and Head of the Department of Pharmaceutical Sciences and Technology at the Institute of Chemical Technology (ICT), Mumbai, India. She obtained her PhD (Tech) in pharmaceutics from the Department of Chemical Technology, University of Mumbai, India. Her research interests include nanocarriers for targeted delivery in cancer and infectious diseases, scale-up of nano drug delivery systems (DDS), bioenhancement strategies, and mucosal DDS as alternatives to parenteral administration for protein and nucleic acid delivery. Prof. Devarajan has supervised more than one hundred master's and doctoral candidates. Her research is funded by the government of India and the national and international pharmaceutical industry. She is an author of several book chapters and has publications in peer-reviewed high impact journals. She has a number of granted patents, with four licensed to the industry. Prof. Devarajan has served as board member, member on the Board of Scientific Advisors and Chair of the Young Scientist Mentor Protégé Sub-committee of the Controlled Release Society. She is a recipient of the American Association of Indian Pharmaceutical Scientists (AAiPS) Distinguished Educator and Researcher Award, the VASVIK award for Industrial Research to Women, and the Association of Pharmaceutical Teachers of India-C.J. Shishoo Award for Research in Pharmaceutical Sciences, and she is a nominated Fellow of the Maharashtra Academy of Sciences, India.



Dr. Sanyog Jain is currently Assistant Professor at the Centre for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Mohali (Punjab), India. He obtained his Ph.D. in pharmaceutics from Dr. Hari Singh Gour University, Sagar (MP), India. His key research interests include exploring nano drug delivery systems for various biomedical applications including targetedanticancer drug